Skip to content

Mining key differentially expressed genes and construction of a prognostic risk score model for colorectal cancer based on bioinformatics.

Oct 2026 · Acta Histochemica · Vol 128 4, pp. 152377 · 0 citations · 36 references
Medicine

Abstract

Colorectal cancer (CRC) remains the third most common malignancy and the second leading cause of cancer-related death worldwide, with limited biomarkers available for accurate prognostic stratification. This study integrates multi-cohort transcriptomic data from four GEO datasets (GSE39582, GSE17536, GSE14333, GSE33113; n = 1123) and the TCGA-CRC cohort (n = 621) to identify key differentially expressed genes and construct a validated prognostic risk score model. Differential expression analysis using the limma framework identified 642 upregulated and 588 downregulated genes (|log2FC|>1, FDR<0.05). Weighted gene co-expression network analysis (WGCNA) extracted hub genes from modules significantly correlated with overall survival. LASSO Cox regression then reduced the hub gene set to an eight-gene prognostic signature (MMP1, AURKA, TOP2A, CDH1, COL1A1, CLDN1, ETV4, CDX2) that stratified patients into high- and low-risk groups with significantly different survival outcomes (p < 0.001, log-rank test). The model achieved AUCs of 0.824, 0.796, and 0.768 for 1-, 3-, and 5-year overall survival in the training cohort and was validated in three independent datasets. High-risk patients exhibited immunosuppressive microenvironments (elevated M2 macrophages, Tregs) and increased resistance to standard chemotherapy agents. Integration of the risk score with clinical variables improved prognostic accuracy (C-index 0.812). These findings offer a robust bioinformatics-derived prognostic tool with implications for immunotherapy patient selection and personalized treatment planning in CRC.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.